Brevan Howard Capital Management LP bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 33,831 shares of the company's stock, valued at approximately $1,806,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Global Retirement Partners LLC increased its position in Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after buying an additional 440 shares during the period. UMB Bank n.a. raised its position in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Larson Financial Group LLC boosted its stake in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after purchasing an additional 250 shares during the period. Optimum Investment Advisors purchased a new position in Doximity during the 4th quarter worth $43,000. Finally, Kapitalo Investimentos Ltda acquired a new position in Doximity in the fourth quarter valued at $50,000. 87.19% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now directly owns 16,618 shares in the company, valued at $946,062.74. The trade was a 10.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now owns 357,165 shares in the company, valued at approximately $20,440,552.95. This trade represents a 11.19 % decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on DOCS shares. Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. Morgan Stanley lowered their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. KeyCorp dropped their target price on Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Truist Financial lowered their price objective on shares of Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Finally, Canaccord Genuity Group upped their price objective on shares of Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $65.39.
Get Our Latest Research Report on DOCS
Doximity Trading Down 0.4 %
Shares of NASDAQ:DOCS traded down $0.25 during midday trading on Friday, hitting $59.10. 1,772,024 shares of the stock were exchanged, compared to its average volume of 2,014,604. The stock has a market cap of $11.03 billion, a P/E ratio of 59.10, a PEG ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21. The company has a 50 day moving average price of $57.99 and a 200-day moving average price of $57.14.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.